Cubist Systematic Strategies’s Arcturus Therapeutics ARCT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $694K | Buy |
+53,357
| New | +$694K | ﹤0.01% | 978 |
|
|
2024
Q4 | – | Sell |
-23,436
| Closed | -$544K | – | 1498 |
|
|
2024
Q3 | $544K | Buy |
+23,436
| New | +$544K | ﹤0.01% | 972 |
|
|
2024
Q2 | – | Sell |
-92
| Closed | -$3.11K | – | 1469 |
|
|
2024
Q1 | $3.11K | Sell |
92
-12,094
| -99% | -$408K | ﹤0.01% | 2084 |
|
|
2023
Q4 | $384K | Buy |
+12,186
| New | +$384K | ﹤0.01% | 1437 |
|
|
2023
Q3 | – | Sell |
-36,817
| Closed | -$1.06M | – | 1977 |
|
|
2023
Q2 | $1.06M | Sell |
36,817
-87,565
| -70% | -$2.51M | 0.01% | 1143 |
|
|
2023
Q1 | $2.98M | Buy |
124,382
+69,517
| +127% | +$1.67M | 0.02% | 894 |
|
|
2022
Q4 | $931K | Buy |
+54,865
| New | +$931K | 0.01% | 1806 |
|
|
2022
Q3 | – | Sell |
-39,749
| Closed | -$626K | – | 3603 |
|
|
2022
Q2 | $626K | Buy |
39,749
+34,514
| +659% | +$544K | ﹤0.01% | 2455 |
|
|
2022
Q1 | $141K | Buy |
+5,235
| New | +$141K | ﹤0.01% | 3122 |
|
|
2021
Q4 | – | Sell |
-15,684
| Closed | -$749K | – | 3451 |
|
|
2021
Q3 | $749K | Buy |
15,684
+6,646
| +74% | +$317K | 0.01% | 1741 |
|
|
2021
Q2 | $306K | Sell |
9,038
-20,042
| -69% | -$679K | ﹤0.01% | 2316 |
|
|
2021
Q1 | $1.2M | Buy |
+29,080
| New | +$1.2M | 0.02% | 1408 |
|
|
2020
Q4 | – | Sell |
-9,962
| Closed | -$427K | – | 2548 |
|
|
2020
Q3 | $427K | Sell |
9,962
-21,638
| -68% | -$927K | 0.01% | 1833 |
|
|
2020
Q2 | $1.48M | Buy |
+31,600
| New | +$1.48M | 0.03% | 965 |
|